Spyre Therapeutics, Inc.

General ticker "SYRE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $9.7B (TTM average)

Spyre Therapeutics, Inc. follows the US Stock Market performance with the rate: 60.6%.

Estimated limits based on current volatility of 2.7%: low 82.10$, high 86.60$

Factors to consider:

  • Total employees count: 30 as of 2016
  • Current price 102.4% above estimated high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [15.49$, 43.22$]
  • 2026-12-31 to 2027-12-31 estimated range: [9.51$, 28.63$]

Financial Metrics affecting the SYRE estimates:

  • Negative: with PPE of -15.9 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Shareholder equity ratio, % of 91.96 > 64.29
  • Positive: -4.41 < Investing cash flow per share per price, % of -1.25

Similar symbols

Short-term SYRE quotes

Long-term SYRE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.89MM $0.00MM $0.00MM
Operating Expenses $243.19MM $208.57MM $209.56MM
Operating Income $-242.30MM $-208.57MM $-209.56MM
Non-Operating Income $-96.51MM $0.60MM $54.34MM
R&D Expense $89.50MM $162.79MM $171.65MM
Income(Loss) $-338.82MM $-207.97MM $-155.22MM
Taxes $-0.03MM $0.05MM $-0.01MM
Net Income(Loss)* $-338.79MM $-208.02MM $-155.20MM
Stockholders Equity $184.02MM $517.80MM $715.24MM
Assets $341.86MM $608.48MM $777.78MM
Operating Cash Flow $-99.91MM $-157.41MM $-169.25MM
Investing Cash Flow $-108.39MM $-353.29MM $-143.47MM
Financing Cash Flow $361.08MM $410.91MM $309.02MM
Earnings Per Share** $-49.12 $-4.42 $-0.45

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.